Table 2 Prevalence of metabolic syndrome and its component factors.

From: Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study

Variable

Overall (n = 453)

Allogeneic (n = 366)

Autologous (n = 87)

P

Metabolic syndrome—IDF definition, n (%)

   

0.33

 No

255 (62.5)

210 (63.6)

45 (57.7)

 

 Yes

153 (37.5)

120 (36.4)

33 (42.3)

 

 Missing

45

36

9

 

Metabolic syndrome—ATPIII definition, n (%)

   

0.56

 No

226 (56.5)

184 (57.1)

42 (53.9)

 

 Yes

174 (43.5)

138 (42.9)

36 (46.2)

 

 Missing

53

44

9

 

Waist circumference, n (%)

   

0.55

 Normal

149 (33.0)

123 (33.6)

26 (30.2)

 

 Elevated

303 (67.0)

243 (66.4)

60 (69.8)

 

 Missing

1

0

1

 

Triglycerides, n (%)

   

0.30

 Normal

186 (48.6)

140 (47.1)

46 (53.5)

 

 Elevated

197 (51.4)

157 (52.9)

40 (46.5)

 

 Missing

70

69

1

 

HDL cholesterol, n (%)

   

0.50

 Normal

273 (63.8)

220 (63.0)

53 (67.1)

 

 Low

155 (36.2)

129 (37.0)

26 (32.9)

 

 Missing

25

17

8

 

Blood pressure, n (%)

   

0.30

 Normal

176 (39.0)

147 (40.2)

29 (34.1)

 

 Elevated

275 (61.0)

219 (59.8)

56 (65.9)

 

 Missing

2

0

2

 

Non-fasting glucose, n (%)

   

0.28

 Normal

371 (88.8)

301 (89.6)

70 (85.4)

 

 Elevated

47 (11.2)

35 (10.4)

12 (14.6)

 

 Missing

35

30

5